𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In Reply to ‘Misuse and Reporting of Renal Endpoints in Randomized Clinical Trials’

✍ Scribed by Katrin Uhlig; Amy Earley; Christopher H. Schmid

Book ID
114470735
Publisher
Elsevier Science
Year
2012
Tongue
English
Weight
492 KB
Volume
59
Category
Article
ISSN
0272-6386

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reporting time-to-event endpoints and re
Reporting time-to-event endpoints and response rates in 4 decades of randomized controlled trials in advanced colorectal cancer
✍ Hendrik-Tobias Arkenau; Ina Nordman; Timothy Dobbins; Robyn Ward 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 244 KB

## Abstract ## BACKGROUND: Reporting of randomized controlled clinical trials (RCTs) often is suboptimal. Cancer drug trials are complicated further by multiple survival and response endpoints. The authors of this report determined the frequency of reporting of time‐to‐event endpoints and tumor re